Richard David Abbott - 13 Aug 2025 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Aug 2025, 16:17:48 UTC
Prior SEC filing
27 May 2025
Next SEC filing
24 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Richard David Abbott

Key filing fact

Richard David Abbott filed Form 4 for Co-Diagnostics, Inc. (CODX) on 15 Aug 2025.

Key facts

  • This page summarizes Richard David Abbott's Form 4 filing for Co-Diagnostics, Inc. (CODX).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 15 Aug 2025, 16:17.

Change

  • Previous filing in this sequence was filed on 27 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002016256 Primary reporting owner

Abbott Richard David

Relationship
President
Address
C/O CO-DIAGNOSTICS, INC., 2401 S. FOOTHILL DRIVE, SUITE D, SALT LAKE CITY
Signature
Richard David Abbott
Signature date
15 Aug 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CODX transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+220,000
Change %
+169%
Price
$0.000000
Shares after
350,438
Date
13 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
130,438
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Granted pursuant to Issuer's 2015 Long Term Incentive Plan, as amended. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's common stock.

Footnote F2

RSU vests in 6 installments commencing on 11/23/25 and continues every 6 months thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .